GlassScriptPhysician profile
John Atwater
NPI 1932115656
$348,348.74
in general payments reported to CMS, 2019-2025
31 companies · $189 in 2025
The $189 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $84K · 2020: $84K · 2021: $74K · 2022: $40K · 2023: $39K · 2024: $27K · 2025: $189.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $61K · Travel and Lodging: $4,111 · Food and Beverage: $1,678.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $60,793.75 |
| Travel and Lodging | $4,111.42 |
| Food and Beverage | $1,678.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nuvasive, INC. | $310,347.15 | 2019-2023 | Nvm5, Xlif, Xlx |
| Globus Medical, INC. | $24,784.45 | 2024 | Nvm5 |
| Mml US, INC. | $3,424.49 | 2022-2025 | Reactiv8 |
| Alphatec Spine, INC | $2,911.14 | 2019 | |
| Medacta USA, INC. | $1,949.06 | 2024 | |
| Aesculap Implant Systems, LLC | $1,299.29 | 2022 | |
| Centinel Spine, LLC | $949.75 | 2021-2022 | |
| Medtronic, INC. | $702.25 | 2021-2022 | |
| Medtronic USA, INC. | $654.60 | 2019 | |
| Si-Bone, INC. | $259.55 | 2022-2025 | |
| Pacira Pharmaceuticals Incorporated | $164.09 | 2024 | Exparel, Zilretta |
| Corelink, LLC | $137.08 | 2022 | |
| Xtant Medical INC | $92.80 | 2025 | |
| Seaspine Orthopedics Corporation | $82.62 | 2019 | |
| Integrity Implants INC. | $79.42 | 2021 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alevio, LLC | $76.49 | 2020 | |
| Zimmer Biomet Holdings, INC. | $48.78 | 2019-2021 | |
| Theragen, INC. | $47.97 | 2021-2023 | Actastim-S |
| Integra Lifesciences Corporation | $45.38 | 2023 | Biofix, Biodoptix, Biodfactor |
| Elevation Spine, INC. | $45.06 | 2024 | |
| Zimvie INC. | $36.45 | 2023 | |
| 4web, INC. | $32.10 | 2020 | |
| Spine Wave, INC. | $24.82 | 2020 | |
| Orthofix Medical, INC. | $23.86 | 2021 | |
| Life Spine, INC. | $23.13 | 2025 | Prolift |
| Augmedics INC. | $23.01 | 2021 | |
| Cerapedics INC. | $22.08 | 2024 | I-Factor Peptide Enhanced Bone Graft |
| Stimwave Technologies Incorporated | $21.25 | 2020 | |
| Boston Scientific Corporation | $13.73 | 2022 | |
| Southern Edge Orthopaedics, INC. | $13.73 | 2025 | |
| Highridge Medical LLC | $13.16 | 2024 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Atwater listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.